Question-based Drug Development for psilocybin
- PMID: 27568265
- DOI: 10.1016/S2215-0366(16)30214-0
Question-based Drug Development for psilocybin
Comment on
-
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.Lancet Psychiatry. 2016 Jul;3(7):619-27. doi: 10.1016/S2215-0366(16)30065-7. Epub 2016 May 17. Lancet Psychiatry. 2016. PMID: 27210031 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources